#arthurhayes

🚀 Zcash (ZEC) jumps 30% in the past 24 hours after Arthur Hayes predicts the privacy token could soar to $10,000.

“Your support helps us deliver fast, accurate, and independent crypto news.”

Arthur Hayes ra mắt quỹ đầu tư 250 triệu USD tập trung vào các công ty tiền mã hóa quy mô trung bình

Văn phòng gia đình của Arthur Hayes đang ra mắt quỹ đầu tư tư nhân đầu tiên, nhằm huy động ít nhất 250 triệu USD để đầu tư vào lĩnh vực tiền mã hóa. Quỹ này tập trung hỗ trợ các công ty quy mô trung bình chuyên cung cấp dịch vụ trong ngành như hạ tầng giao dịch, phân tích dữ liệu và nền tảng công nghệ.

Mỗi khoản đầu tư dao động từ 40 đến 75 triệu USD, hướng đến tối đa sáu doanh nghiệp. Sáng kiến này thể hiện niềm tin của Hayes vào tiềm năng tăng trưởng dài hạn của hệ sinh thái tiền mã hóa, tập trung vào các doanh nghiệp nền tảng thay vì tài sản đầu cơ. Bằng cách đầu tư vào các công ty cung cấp dịch vụ, quỹ hướng đến củng cố hạ tầng ngành và thúc đẩy sự phát triển bền vững.

Arthur Hayes, co-founder of BitMEX, has lived a whirlwind career. He built one of the largest crypto trading platforms in the world, faced legal battles, and later received a presidential pardon. Today, Hayes is moving his focus from digital assets to longevity investments. This crypto biohacking shift marks a new phase of his journey, where financial success fuels his pursuit of health and extended life.

Hayes Embraces Stem Cell Therapy

Instead of limiting himself to crypto markets, Hayes has taken a bold step into the biohacking space. He recently invested in a stem cell company with clinics in Mexico and Bangkok. For over a year, he has traveled frequently to these clinics for stem cell infusions aimed at extending his healthspan. In a recent video interview, Hayes explained his motivation. “I want to live as long as possible, as healthy as possible,” he said. He believes stem cell therapy represents the future, noting that more countries are beginning to relax regulations around its use. His crypto biohacking shift highlights how top executives are now using their wealth to challenge traditional health boundaries.

A Presidential Pardon and a New Path

Earlier this year, former U.S. President Donald Trump pardoned Hayes along with BitMEX co-founders Benjamin Delo and Samuel Reed. The three had been charged in 2020 for violating the Bank Secrecy Act. By 2022, they pleaded guilty, paid $10 million each, and received probation. Even before the pardon, Hayes was living comfortably in Singapore and spending part of the year skiing in Japan. His widely read essays on markets, meme culture, and monetary theory continued to influence crypto circles. In fact, one of his posts in 2023 inspired the creation of Ethena’s synthetic dollar, now the third-largest stablecoin by market value. Yet, despite these accomplishments, his crypto biohacking shift shows that his ambitions stretch far beyond financial markets.

Crypto Wealth Meets Longevity Dreams

Hayes is not alone in this new pursuit. Other industry leaders are also pouring capital into health and biotech. Ethereum co-founder Vitalik Buterin has donated millions to life-extension research. Coinbase CEO Brian Armstrong co-founded NewLimit, a genetic engineering startup that recently raised $130 million. Former Coinbase CTO Balaji Srinivasan has also invested heavily in biotech. The crypto biohacking shift is therefore not a personal decision alone. Instead, it represents a broader movement among crypto pioneers who want to live longer while continuing to disrupt industries.

Market Shifts and New Risks

Alongside health ventures, Hayes continues to watch crypto markets closely. His family office, Maelstrom, has backed three digital asset treasury companies (DATs). These firms accumulate crypto on their balance sheets and now hold nearly $110 billion worth of Bitcoin, according to CoinGecko. However, Hayes has warned that the surge in DATs could overheat the market. He argues that only those that can attract passive institutional investors will succeed. Otherwise, many treasury companies risk trading at discounts, which could destabilize the broader rally.

The Future of Hayes’s Journey

Arthur Hayes, co-founder of BitMEX, has lived a whirlwind career. He built one of the largest crypto trading platforms in the world, faced legal battles, and later received a presidential pardon. Today, Hayes is moving his focus from digital assets to longevity investments. This crypto biohacking shift marks a new phase of his journey, where financial success fuels his pursuit of health and extended life.

Hayes Embraces Stem Cell Therapy

Instead of limiting himself to crypto markets, Hayes has taken a bold step into the biohacking space. He recently invested in a stem cell company with clinics in Mexico and Bangkok. For over a year, he has traveled frequently to these clinics for stem cell infusions aimed at extending his healthspan. In a recent video interview, Hayes explained his motivation. “I want to live as long as possible, as healthy as possible,” he said. He believes stem cell therapy represents the future, noting that more countries are beginning to relax regulations around its use. His crypto biohacking shift highlights how top executives are now using their wealth to challenge traditional health boundaries.

A Presidential Pardon and a New Path

Earlier this year, former U.S. President Donald Trump pardoned Hayes along with BitMEX co-founders Benjamin Delo and Samuel Reed. The three had been charged in 2020 for violating the Bank Secrecy Act. By 2022, they pleaded guilty, paid $10 million each, and received probation. Even before the pardon, Hayes was living comfortably in Singapore and spending part of the year skiing in Japan. His widely read essays on markets, meme culture, and monetary theory continued to influence crypto circles. In fact, one of his posts in 2023 inspired the creation of Ethena’s synthetic dollar, now the third-largest stablecoin by market value. Yet, despite these accomplishments, his crypto biohacking shift shows that his ambitions stretch far beyond financial markets.

Crypto Wealth Meets Longevity Dreams

Hayes is not alone in this new pursuit. Other industry leaders are also pouring capital into health and biotech. Ethereum co-founder Vitalik Buterin has donated millions to life-extension research. Coinbase CEO Brian Armstrong co-founded NewLimit, a genetic engineering startup that recently raised $130 million. Former Coinbase CTO Balaji Srinivasan has also invested heavily in biotech. The crypto biohacking shift is therefore not a personal decision alone. Instead, it represents a broader movement among crypto pioneers who want to live longer while continuing to disrupt industries.

Market Shifts and New Risks

Alongside health ventures, Hayes continues to watch crypto markets closely. His family office, Maelstrom, has backed three digital asset treasury companies (DATs). These firms accumulate crypto on their balance sheets and now hold nearly $110 billion worth of Bitcoin, according to CoinGecko. However, Hayes has warned that the surge in DATs could overheat the market. He argues that only those that can attract passive institutional investors will succeed. Otherwise, many treasury companies risk trading at discounts, which could destabilize the broader rally.

The Future of Hayes’s Journey

Former BitMEX CEO Arthur Hayes just delivered one of the most contrarian yet compelling Bitcoin analyses we've seen this year. While everyone's riding the Trump pump euphoria, Hayes is warning of a brutal correction to $90,000 before the real fireworks begin.

The Macro Setup: Why Hayes Sees Red Ahead

Hayes isn't just throwing numbers around - his "Quid Pro Stablecoin" thesis breaks down the exact mechanics behind his prediction. The Treasury General Account refill could drain liquidity from markets between now and Jackson Hole in August, creating the perfect storm for a Bitcoin correction.

But here's where it gets interesting: Hayes sees this dip as the setup for the most explosive rally in crypto history.

The Stablecoin Game Changer

The real alpha in Hayes's analysis isn't the short-term bearishness - it's his thesis on bank-issued stablecoins. When giants like JPMorgan launch regulated USD-backed tokens, they'll unlock something unprecedented: $6.8 trillion in potential Treasury bill demand from tokenized bank deposits.

This isn't your typical DeFi speculation. We're talking about traditional banks channeling retail deposits into blockchain infrastructure, creating liquidity injection comparable to quantitative easing without the Fed lifting a finger.

Why This Time Is Different

Unlike previous cycles driven purely by retail FOMO or institutional adoption, this wave could be powered by structural changes in how banks operate. Hayes estimates that banks could save $20 billion annually through tokenized deposit automation, creating massive incentives for rapid adoption.

The implications for Bitcoin are staggering. When trillions in new liquidity enter the system through regulated stablecoin channels, risk assets like Bitcoin become the primary beneficiaries of this monetary expansion.

Professional Trading Perspective

For sophisticated traders monitoring these macro developments through platforms like https://www.nkscx.com/, Hayes's framework provides a compelling roadmap for positioning ahead of major market shifts.

The key insight: temporary liquidity drains create buying opportunities before structural liquidity injections drive the next bull market phase.

The $250k Vision

Hayes maintains his bold $250,000 Bitcoin target by year-end, contingent on his stablecoin thesis playing out. If bank-issued tokens capture even a fraction of the $17 trillion in US bank deposits, the resulting liquidity wave could dwarf previous crypto rallies.

This isn't just price speculation - it's a fundamental reimagining of how traditional finance interfaces with digital assets through regulatory-compliant infrastructure.

The setup Hayes describes could mark crypto's transition from speculative asset class to integral component of the traditional financial system, powered by institutions rather than retail enthusiasm.

Bottom line: Hayes is betting that short-term pain sets up long-term structural gains as stablecoins bridge traditional banking with crypto markets.